(40) concluded after in vivo experiments that H19 disrupts the balance between osteogenesis and osteolysis through Akt/mTOR signal transduction, leading to reduced osteogenic activity and increased osteoclast activity, promoting the occurrence and development of MM. The gene discussed is H19; the disease is Miyoshi myopathy.